Hyaluronic-acid filler under the eyes produces visible hollow correction for most patients, with 91.0% overall satisfaction in a 31-report meta-analysis, but it isn't a fix for bags, pigmentation, or loose skin. The right before-and-after result depends less on filling every shadow and more on identifying what creates that shadow in the first place.
The most popular advice is to find a dramatic gallery photo and ask for the same product. That's backwards. A strong result starts with a diagnosis of the under-eye concern, conservative placement, and photographs that show the face after the early swelling has settled, ideally including a six-month follow-up.
A polished day-three image may show a smoother lid-cheek transition, but it can also reflect swelling, favorable lighting, a lifted brow, or a carefully chosen expression. In consultation, I want to know whether the patient has a true hollow, a protruding fat pad, festoons, pigmentation, thin lax skin, or several of these at once.
| Under-eye concern | What filler can change | What usually needs another approach |
|---|---|---|
| True tear-trough hollow | Replaces lost volume and softens shadowing | Significant skin laxity or fat prolapse |
| Mild volume loss with good skin | Creates a smoother lid-cheek transition | Prominent bags or fluid retention |
| Pigmentation-dominant darkness | May soften shadow-related contrast | Melanin, vascular color, or hemosiderin |
| Lower-lid bags | Usually limited benefit | Fat prolapse or excess skin |
| Festoons and edema | Often poor candidate | Fluid retention and malar swelling |
Table of Contents
- What Tear Trough Filler Actually Does
- Candidacy by Cause Not Just by Shadow
- Filler Types Compared for the Tear Trough
- Appointment Day and the Two-Week Recovery Timeline
- How Long Results Actually Last
- Common Side Effects and the Rare Emergencies
- Choosing Between Filler and Your Other Options
- Questions Patients Ask After They See the Gallery
What Tear Trough Filler Actually Does
A strong under-eye result starts with an unglamorous truth. Tear trough filler corrects a ligament-bound depression near the junction of the lower eyelid and cheek. It does not treat every reason the under-eye looks dark, hollow, puffy, or tired.
Patients often use “under-eye area” as a catchall for the inner-corner hollow, cheek shadow, blue or brown discoloration, lower-lid bags, and fine crepey skin. Those can appear together in one face and still require different decisions. In practice, that distinction matters more than any polished before-and-after image.
Hyaluronic-acid filler is used to place a soft gel in or near the infraorbital hollow, with the goal of restoring lost volume, supporting the lid-cheek transition, and reducing the shadow cast by the orbital rim. It does not tighten loose skin, remove a prolapsing fat pad, erase pigment, or fix every cause of a fatigued appearance. It also carries real limits and rare vascular risks, which is why the best galleries are not the ones with the flashiest day-three photos. They are the ones that show settled results and careful patient selection.
How to read the photograph
Read the anatomy first. Then read the photo.
- Match the angle. A slight turn of the face can deepen or flatten the hollow.
- Match the light. Overhead lighting sharpens grooves, while diffuse frontal light can soften or hide them.
- Match the expression. Smiling, squinting, or brow elevation changes the lower-lid contour.
- Check the timing. Immediate post-treatment images may show swelling or temporary fullness.
- Look for late follow-up. Six-month photographs are far more useful than early recovery images.
The best quantitative summary comes from a 2023 systematic review of tear-trough hyaluronic-acid filler outcomes, which combined 31 reports and 2,556 participants and found pooled overall satisfaction of 91.0%, with a 95% confidence interval of 84.9% to 95.7%. That supports careful optimism. Outcomes still depend on anatomy, product choice, depth of placement, technique, and injector experience.
Practical rule: A credible before-and-after photo shows a contour change under comparable conditions and at a settled follow-up. It does not show that the same treatment belongs on every face.
Candidacy by Cause Not Just by Shadow
A shadow isn't a diagnosis. Two patients can show similar darkness in a selfie and need completely different recommendations.
Start with the dominant cause
Volume loss is the clearest filler indication. When the deep malar fat and infraorbital support have diminished, a conservative amount of hyaluronic acid can soften the depression and reduce the contrast between the lower eyelid and cheek.
True eye bags are different. A protruding lower-lid fat pad creates fullness, not a deficit. Adding more volume directly beneath or around that fullness can make the area look heavier. In those cases, lower blepharoplasty or fat repositioning may be more logical than injection.
Festoons and lymphatic edema also deserve caution. These are fluid-prone or structurally prominent areas where filler can add volume to the wrong problem. Persistent puffiness, morning swelling, and fullness over the cheekbone should make an injector slow down rather than reach for more product.
Pigmentation may be brown, blue, purple, or mixed. Filler can reduce a shadow that makes pigment appear darker, but it won't remove melanin or vascular color. For a broader overview of topical approaches, patients can review these dark circle serum ingredients, while understanding that skincare addresses skin quality rather than replacing lost structural volume.
Use a simple mirror test
Stand in natural light with your face relaxed. Gently stretch the lower-lid skin toward the temple, then tilt your head slightly upward.
If the dark groove improves when the skin is supported and the main issue is a depression, volume loss may be contributing. If the bag remains prominent, the skin looks loose, or swelling changes substantially from morning to evening, filler may not be the right first treatment.
Skin laxity with poor recoil, pronounced folds, festoons, or visible fat prolapse should redirect the consultation toward tightening, surgery, skincare, or no treatment. A 2024 anatomic study of 123 participants reported improvement in hyperpigmentation scores at six months with a conservative “bridge the gap” approach, and all recorded adverse events resolved within two weeks, with no observed Tyndall effect (anatomic study of conservative tear-trough correction). The lesson is not that filler treats pigmentation universally. It's that strategic, limited placement may outperform aggressive filling when a hollow contributes to the visual problem.
Filler Types Compared for the Tear Trough
Product choice is a clinical decision, not a shopping list. The under-eye needs a material that integrates in thin tissue, provides enough support to soften the hollow, and doesn't create visible swelling or a blue-gray cast.
Two products now have specific U.S. Food and Drug Administration indications for infraorbital hollows. Juvéderm Volbella XC received approval for correction of infraorbital hollows in 2022, and Restylane Eyelight received approval in 2023 after a randomized, evaluator-blinded, multicenter Phase 3 study. For Juvéderm Volbella XC, reported study results cited one year after treatment found that 74% of trial participants remained satisfied and continued to demonstrate improvement (FDA approval information for Restylane Eyelight and the development of dedicated under-eye indications).
Other hyaluronic-acid products may be used off-label depending on the injector's assessment. Options can include softer, finely integrating formulations and products from families such as Restylane-L, Belotero Balance, and the RHA line. Their suitability depends on tissue thickness, the depth of the hollow, skin quality, edema tendency, and whether the injector is treating the trough directly or supporting the cheek first.
Tear Trough Filler Options at a Glance
| Product | FDA Tear-Trough Indication | Best-Fit Anatomy | Swelling Profile |
|---|---|---|---|
| Juvéderm Volbella XC | Specific indication for infraorbital hollows | Mild to moderate volume-related hollowing with suitable skin | Product and technique dependent, generally selected for subtle integration |
| Restylane Eyelight | Specific indication for infraorbital hollows | Infraorbital volume loss assessed as appropriate on examination | Product and technique dependent, with conservative placement important |
| Restylane-L | Commonly used off-label in selected cases | Patients needing tailored hyaluronic-acid support | Can be less forgiving when placement or volume is excessive |
| Belotero Balance | Commonly used off-label in selected cases | Fine contour transitions and carefully selected superficial concerns | Requires attention to visibility and tissue thickness |
| RHA line | Commonly used off-label in selected cases | Dynamic facial movement and individualized structural support | Depends on formulation, plane, anatomy, and amount used |
I don't consider Sculptra or Radiesse first-line choices for a direct tear-trough correction. Biostimulatory or firmer materials can be difficult to control in a delicate, thin-skinned region, and they don't offer the same straightforward reversibility as hyaluronic acid.
Patients researching treatment for apparent lower-lid bags can also review this clinical overview of Restylane for under-eye bags, but the product name should never replace an anatomical assessment. The best filler is the one that fits the tissue, not the one that looks most impressive in an advertisement.
Appointment Day and the Two-Week Recovery Timeline
The appointment is often shorter than patients expect. The decision-making should not be. Before any injection, I review prior filler, allergies, medications, skin history, baseline photographs, and, just as important, why the under-eye looks tired in the first place. A hollow behaves differently from a bag, pigment, or lid laxity, and that difference shapes both the plan and the photos you should trust afterward.
Consent has to be plainspoken. Under-eye filler can bruise, swell, create contour irregularities, or leave delayed lumps. Rare vascular complications, including visual injury, also belong in that discussion, even if many before-and-after galleries skip over them.
Topical anesthetic may be enough, though some patients need local anesthetic as well. The injection portion is usually brief, often 15 to 30 minutes, but careful assessment, marking, photography, and conservative dosing are what protect the result.
What the first two weeks can look like
Early photos are often the most flattering and the least informative. Day-three pictures can look polished or puffy, depending on swelling, lighting, and how readily the tissue holds fluid. I prefer comparison images at two weeks, and I put more weight on six-month photos than on polished early snapshots.
A multicenter series of 151 patients and 302 treated eyes reported cosmetic improvement in all patients reviewed at about three weeks. Ninety-seven percent described moderate or marked satisfaction, and 18% asked for additional product at one month. Immediate reactions included bruising in 11%, swelling in 12%, and injection-site redness or inflammation in 12%, with no serious adverse events recorded in that series (multicenter case series of semi-cross-linked hyaluronic-acid filler).
- Day 1: Mild tenderness, redness, tiny injection marks, and uneven swelling are common. Symmetry is not ready for judgment.
- Day 3: Swelling may still make the area look overfilled or irregular. This is a poor day to decide whether treatment “worked.”
- Day 7: Bruising often fades, but thin skin and fluid-prone tissue can still look fuller than the final result.
- Day 14: Contour is usually easier to assess. This is a sensible review point, not an automatic refill visit.
- One month: Add more only if reassessment shows a true residual hollow.
Aftercare is straightforward. Avoid rubbing the area, use cold compresses in short intervals, sleep with your head raised, and follow instructions about makeup. Many clinicians recommend avoiding makeup for 12 to 24 hours and strenuous exercise for 24 to 48 hours, depending on the procedure and your medical history. Use the same lighting, angle, expression, and camera distance for follow-up photos if you want a fair before-and-after comparison.
How Long Results Actually Last
The phrase “12 to 18 months” is too blunt for a delicate area. Product persistence, visible correction, and the point at which a patient wants a touch-up aren't identical milestones.
A retrospective study of 155 patients treated from 2007 through 2023 used the validated Merz Infraorbital Hollow Assessment Scale to compare standardized photographs. Most patients improved by at least one severity grade, and statistically significant improvement persisted through 18 months, with no significant difference in grade change across the six-, 12-, and 18-month follow-ups (retrospective MIHAS-based study of tear-trough filler outcomes).
What changes the timeline
A patient may still have filler in the tissue but no longer see the same improvement. Metabolism, facial movement, skin quality, age-related volume shifts, lifestyle, product characteristics, and the original severity of the hollow all influence how long the result looks convincing.
My practical approach is to schedule a low-stakes review around month nine to 12, then touch up only if the hollow is visibly returning. A maintenance plan should preserve a natural transition, not keep adding product because a calendar reminder says it's time.
Patients comparing longevity across treatment areas can also read this overview of the longest-lasting dermal filler options. The important distinction is that “lasting longer” doesn't justify overfilling the under-eye. Excess product can create persistent puffiness, heaviness, or contour irregularity, especially when the original concern was a bag or edema rather than a hollow.
Common Side Effects and the Rare Emergencies
Before-and-after photos almost never show the part that matters most in a consent discussion: how a clinic distinguishes expected recovery from a true emergency. Day-three images can look polished. They do not show whether the patient had swelling for two weeks, whether a lump declared itself later, or whether the injector recognized vascular compromise fast enough to act.
For that reason, I tell patients to judge under-eye filler with the same standard I use in consultation. Look past the early photo. Ask what happened at six months, and ask what can go wrong.
The common tier
Most post-treatment issues are nuisance problems, not disasters. In the tear trough, the usual ones are swelling, bruising, temporary redness, contour irregularity, palpable product, and the blue-gray cast known as the Tyndall effect. Thin lower-lid skin and a dense superficial blood supply make all of these more likely than patients expect from a small-volume treatment.
Cause matters here too. A patient treated for a true hollow may accept a few days of puffiness and still end up with a cleaner lid-cheek transition. A patient who already has fluid retention, a malar bag, or lower-lid laxity can interpret that same puffiness as a bad result, because filler did not address the underlying anatomic problem.
A systematic review summarized by the American Academy of Ophthalmology summary of tear-trough filler evidence reported high patient satisfaction overall, with bruising, edema, and lumpiness among the more frequent side effects. It also noted an important limitation: rare but serious events may be underrepresented when small case reports are excluded.
Redness around the eyes also has a long list of unrelated causes. Patients comparing symptoms sometimes look up why lashes cause red eyes. That can be useful context, but irritation from adhesive, friction, or the lid margin is a different problem from filler-related vascular compromise. Timing, pattern, pain level, and exam findings separate them.
The rare emergency tier
The emergency conversation should be blunt. Vascular complications are uncommon, but they are recognized risks of tear-trough filler. Reported events include ischemic skin injury, necrosis, retrobulbar hemorrhage, and blindness. Those are rare outcomes, not theoretical ones, and galleries often skip them because they are hard to market and impossible to glamorize.
Patients should contact the clinic immediately, or follow its emergency instructions, for any of the following:
- New visual disturbance: blurred, dimmed, double, or lost vision
- Escalating pain: pain that is severe, worsening, or out of proportion to typical tenderness
- Pale or mottled skin: blanching, gray discoloration, or an unusual livedo-like pattern
- Rapid one-sided swelling: increasing tension or asymmetry that develops quickly
Ask practical safety questions before anyone injects. Who answers after hours? Is hyaluronidase on site? Hyaluronic-acid filler has one major safety advantage. It can be dissolved. That does not make treatment risk-free, and it does not replace judgment, speed, or experience when a warning sign appears.
Choosing Between Filler and Your Other Options
The right decision follows the dominant anatomy. A patient with a deep hollow and smooth skin may benefit from conservative hyaluronic-acid filler, while someone with a bag, festoon, or lax lower lid may look worse after an injection.
| Presentation | More logical first consideration |
|---|---|
| Deep hollow with limited puffiness | Conservative hyaluronic-acid filler |
| Mild hollow with good skin but early laxity | Conservative filler, possibly combined with skin-tightening treatment |
| Mixed bag and hollow | Lower blepharoplasty or fat repositioning, with filler considered only after structural assessment |
| Pigmentation-dominant darkness | Pigment-focused skincare, selected laser treatment, or camouflage strategies |
| Cheek-driven shadow | Midface or cheek support may be more natural than direct trough filling |
Direct trough injection isn't always the best way to improve a trough. If the cheek has lost support, treating the broader transition may reduce the shadow without placing a visible mound beneath the lower eyelid. Conversely, adding cheek volume to a patient with existing fullness can create a different problem, so the plan must follow the exam.
At the Atlanta and Marietta offices, Georgia Plastic & Reconstructive Surgery combines surgical consultations with the on-site AmaChi MedSpa, allowing a patient to discuss filler, blepharoplasty, and energy-based treatments such as Morpheus8 within the same broader facial assessment. Patients comparing topical options can also use this dupe-style eye cream guide for budget shoppers, but an affordable eye cream can't replace surgery for fat prolapse or filler for true structural volume loss.
Bring reference photos that show the look you want, then ask a more useful question than “Which product do I need?” Ask, “What is causing my shadow, and what would make it worse?” For patients with genuine lower-lid bags, this guide to under-eye bag surgery and recovery can help frame the surgical conversation.
Questions Patients Ask After They See the Gallery
Why can filler make my bags or puffiness look worse?
Filler adds volume. If the dominant problem is a protruding fat pad, festoon, or lymphatic edema, extra volume can make the area look fuller instead of smoother. A good consultation may end with no injection, cheek support, skincare, or surgery.
How should I judge before-and-after photographs?
Look for matched lighting, camera angle, facial expression, and follow-up timing. Prefer images taken after the early swelling has resolved, and look for a six-month result rather than relying on a polished day-three photograph.
Should I pause retinol, skincare, or facials?
Tell the injector about every active product and recent procedure. Active dermatitis, irritation, or recent laser treatment can increase sensitivity and swelling risk, so your clinician may adjust timing or ask you to pause selected products.
What if the result looked good at two weeks but became puffy at two months?
Don't keep adding filler to correct fullness. Schedule an examination to distinguish delayed edema, misplaced or excessive hyaluronic acid, a developing contour issue, or an unrelated change. If hyaluronic-acid filler is contributing, hyaluronidase may be considered by a qualified clinician.
Georgia Plastic & Reconstructive Surgery offers facial filler consultations, surgical evaluation, and non-surgical options across its Atlanta and Marietta locations, including assessment for tear-trough hollows, lower-lid bags, skin laxity, and cheek support. Visit Georgia Plastic & Reconstructive Surgery to request a consultation focused on the cause of your under-eye concern, not the product shown in a gallery.
